NEWS

Developing an innovative new drug platform with the technology for selecting
and producing high-sensitivity and high-efficiency antibodies and the recombinant fusion protein technology

Clinical performance test
  • News
  • Clinical performance test
  • No posts.
Contact us
Head Office : BIO-1 310, 32, Soyanggang-ro, Chuncheon-si, Gangwon State, Republic of Korea
Corporate Research Institute : 2F, 199-9, Dugaebisan-ro, Bukbang-myeon, Hongcheon-gun, Gangwon State, Republic of Korea
  • Tel : 070-4254-4498
  • Fax : 033-258-6416
  • E-mail : sales@hauulbio.com